McNicoll Lewis & Vlak Starts Unilife Corporation (UNIS) at Buy, Price Target $8
McNicoll Lewis & Vlak initiates coverage on shares of Unilife Corporation (NASDAQ: UNIS) with a Buy rating and a $8 fair value estimate.
The company develops and manufactures highly differentiated safety syringes for use by pharmaceutical companies and healthcare facilities.